Key result
Comprehensive review outlines optimal statin prescribing, mechanisms, and safety for managing hypercholesterolemia.
This review provides a comprehensive overview of statin medications, including their mechanism of action, administration, and monitoring for the management of hypercholesterolemia.
Statin medications are utilized regarding the management of hypercholesteremia. Statins are inhibitors of hydroxymethylglutaryl-CoA reductase enzyme and lower total cholesterol, low-density lipoprotein (LDL), and triglyceride concentrations. The FDA-approved statins are atorvastatin, rosuvastatin, simvastatin, pravastatin, fluvastatin, lovastatin, and pitavastatin. Individuals at high risk for atherosclerotic cardiovascular disease need more aggressive management strategies along with higher-intensity statin therapy. The mechanisms of action, dosage guidelines, clinical toxicology, possible drug interactions, pharmacokinetics, and monitoring techniques pertaining to healthcare practitioners' management of hypocholesteremia are reviewed by participating clinicians. The importance of coronary artery calcium scoring in unclear conditions is highlighted. The interprofessional team learns the optimal statin prescribing guidelines from this activity.
No takes yet. Share an insight, caveat, or question.
E. et al. (2026) conducted a review in Hypercholesteremia. Statin medications was evaluated. Statin medications, which inhibit HMG-CoA reductase to lower cholesterol, are reviewed for their mechanisms, dosage, toxicology, and optimal prescribing guidelines for managing hypercholesteremia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: